NCT01707901View on ClinicalTrials.gov

A Study of the Effect of ONO-8539 on Oesophageal Pain Hypersensitivity in Patients With Non-erosive Reflux Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2014

Conditions
GERD
Interventions
DRUG

ONO-8539

Treatment

OTHER

Placebo

Placebo

Trial Locations (2)

B-3000

Leuven Clinical site, Leuven

E1 2AJ

London Clinical site, London

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY